Advertisement
Advertisement

SKYE

SKYE logo

Skye Bioscience, Inc. Common Stock

0.86
USD
Sponsored
-0.04
-3.96%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

0.85

-0.01
-1.24%

Skye Bioscience, Inc. Common Stock Profile

About

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

Info & Links

CEO

Punit Dhillon

Headquarters

11250 EL CAMINO REAL, SUITE 100
SAN DIEGO, CA 92130, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.skyebioscience.com

Auditor

Marcum LLP

Share holders

181

Employees

12

Skye Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

29.93M

Enterprise Value

24.05M

Enterprise Value/EBITDA(ttm)

-0.42

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.16

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-143.59%

Return on Invested Capital(ttm)

-170.06%

Return on Assets(ttm)

-119.89%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-57.44M

Net Income Available to Common(ttm)

-55.92M

Diluted EPS(ttm)

-1.40

Share Statistics

Beta (5Y Monthly)

2.87

52-Week Change

-51.80%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

33.38M

Dividend Yield

0.00%

Float4

33.55M

% Held by Insiders

4.50%

% Held by Institutions

21.09%

Balance Sheet

Total Cash(mrq)

25.74M

Total Cash Per Share(mrq)

0.77

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.30%

Quick Ratio(mrq)

3.30%

Book Value Per Share(mrq)

0.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.09

Free Cash Flow(ytd)

-42.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement